People
Deborah Ramsdell
Rare-disease biotechnology executive with clinical, regulatory and company-building experience; appointed CEO August 24, 2026.
Roles
Pluvia Biotech
CurrentChief Executive Officer
People
Rare-disease biotechnology executive with clinical, regulatory and company-building experience; appointed CEO August 24, 2026.
Chief Executive Officer